EMA publishes its annual reports in May / June following the year in question.
EMA also publishes information on the volume and outcome of centralised procedures for human and veterinary medicines. For further details, see Medicine evaluation figures.
EMA’s work programmes (now called programming documents) reflect the priorities and main focus areas of EMA and of the European medicines regulatory network for the corresponding period and describe objectives and planned activities. They cover:
- human medicines evaluation activities, split into pre-authorisation, initial evaluation, post-authorisation, pharmacovigilance and referrals;
- veterinary medicines evaluation activities, with a similar structure to the human medicines chapter;
- horizontal activities that enable and support the evaluation of human and veterinary medicines. These include committee coordination, inspections, partner and stakeholder relationship management, and data management;
- corporate governance and support activities, including finance, human resources and quality management.
2022 annual report
EMA's 2022 annual report highlights the Agency's most significant achievements in 2022.
This includes EMA's core regulatory activities to protect public and animal health in the EU, and the European medicines regulatory network’s response to COVID-19 and monkeypox.
It also highlights EMA's activities to implement new EU legislation reinforcing the Agency's role in preparing for and managing crisis situations affecting the EU single market for medicines and medical devices.
The report is available in two formats:
- Digital version: view online for an interactive timeline of EMA’s main activities in 2022 plus visuals and audio-visual materials exploring topics in depth
- PDF version: downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities
2024
Final programming document 2024-2026
2022
EMA's annual report 2022 is available in two formats:
- Digital version: view online for an interactive timeline of EMA’s main activities in 2022 plus visuals and audiovisual materials exploring topics in depth
- PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.
2022 annual report of the European Medicines Agency
Annexes - 2022 annual report of the European Medicines Agency
Annex 10 - 2022 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Final programming document 2022-2024
Annual activity report 2022
European Medicines Agency mid-year report 2022 (January-June 2022)
2021
EMA's annual report 2021 is available in two formats:
- Digital version: view online for an interactive timeline of EMA’s main activities in 2021 plus visuals and audiovisual materials exploring topics in depth
- PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.
2021 annual report of the European Medicines Agency
Annexes - 2021 annual report of the European Medicines Agency
Annex 10 - 2021 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Final programming document 2021-2023
Annual activity report 2021
European Medicines Agency mid-year report 2021 (January-June 2021)
2020
EMA's annual report 2020 is available in two formats:
- Digital version: view online for an interactive timeline of EMA’s main activities in 2020 plus visuals exploring topics in depth
- PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.
2020 annual report of the European Medicines Agency
Annexes - 2020 annual report of the European Medicines Agency
Annex 10 - 2020 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Annual activity report 2020
Final programming document 2020-2022
European Medicines Agency mid-year report 2020 (January-June 2020)
2019
EMA's annual report 2019 is available in two formats:
- Digital version with an interactive timeline of EMA's main activities in 2019 and key figures for the year;
- PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.
2019 annual report of the European Medicines Agency
Annexes - 2019 annual report of the European Medicines Agency
Annex 10 – 2019 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Annual activity report 2019
European Medicines Agency mid-year report 2019 from the Executive Director
Final programming document 2019-2021
2018
2018 annual report of the European Medicines Agency
Annexes - 2018 annual report of the European Medicines Agency
Annex 10 – 2018 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Annual activity report 2018
Multiannual work programme 2018-2020
Annual report 2018 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)
2017
2017 annual report of the European Medicines Agency
Annexes - 2017 annual report of the European Medicines Agency
Annex 10 – 2017 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Annual activity report 2017
Work programme of the European Medicines Agency 2017
2016
2016 annual report of the European Medicines Agency
Annexes - 2016 annual report of the European Medicines Agency
Annex 10 – 2016 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication
Annual activity report 2016
European Medicines Agency mid-year report 2016 from the Executive Director
Multiannual work programme to 2020
Work programme of the European Medicines Agency 2016
Annual report 2016 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)
2015
Annual activity report 2015
2015 annual report of the European Medicines Agency
Annexes - 2015 annual report of the European Medicines Agency
Annex 10 - 2015 annual report of the European Medicines Agency - Positive and negative opinions; Withdrawn applications
European Medicines Agency mid-year report 2015 from the Executive Director
Work programme of the European Medicines Agency 2015
Annual reports for the period from 2012 to 2015 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)
2014
Annual report of the European Medicines Agency 2014
Annexes to the annual report of the European Medicines Agency 2014
Annual activity report 2014
Work programme of the European Medicines Agency 2014
2013
Annual report of the European Medicines Agency 2013
Annexes to the annual report of the European Medicines Agency 2013
Work programme of the European Medicines Agency 2013
2012
Annual report of the European Medicines Agency 2012
Annexes to the annual report of the European Medicines Agency 2012
Work programme of the European Medicines Agency 2012
2011
Annual report of the European Medicines Agency 2011
Annual report 2011 (Annexes)
Work programme of the European Medicines Agency 2011
2010
Summary of the annual report of the European Medicines Agency 2010
Annual report of the European Medicines Agency 2010
Annual report 2010 (Annexes)
Work programme for the European Medicines Agency 2010
2009
Summary of the annual report of the European Medicines Agency 2009
Annual report of the European Medicines Agency 2009
Annual report 2009 (Annexes)
Work programme for the European Medicines Agency 2009
2008
Summary of the European Medicines Agency’s annual report for 2008
Annual report of the European Medicines Agency 2008
Work programme for the European Medicines Agency 2008
Summary of the work programme for the European Medicines Agency 2008
2007
Summary of the European Medicines Agency’s annual report for 2007
Annual report of the European Medicines Agency 2007
Summary of the work programme for the European Medicines Agency 2007
Work programme for the European Medicines Agency 2007
2006
Summary of the European Medicines Agency’s annual report for 2006
Annual report of the European Medicines Agency 2006
Summary of the work programme for the European Medicines Agency 2006
Work programme for the European Medicines Agency 2006
2005
Summary of the annual report of the European Medicines Agency 2005
Annual report of the European Medicines Agency 2005
Work programme for the European Medicines Agency 2005
1995-2004
Annual report of the European Medicines Agency 2004
Work programme for the European Agency for the Evaluation of Medicinal Products 2004
Annual report of the European Agency for Evaluation of Medicinal Products 2003
Work programme for the European Agency for the Evaluation of Medicinal Products 2003
Annual report of the European Agency for the Evaluation of Medicinal Products 2002
Work programme for the European Agency for the Evaluation of Medicinal Products 2002
Annual report of the European Agency for Evaluation of Medicinal Products 2001
Work programme for the European Agency for the Evaluation of Medicinal Products 2001-2002
Annual report of the European Agency for Evaluation of Medicinal Products 2000
Work programme for the European Agency for the Evaluation of Medicinal Products 2000-2001
Annual report of the European Agency for Evaluation of Medicinal Products 1999
Work programme for the European Agency for the Evaluation of Medicinal Products 1999-2000
Annual report of the European Agency for Evaluation of Medicinal Products 1998
Work programme for the European Agency for the Evaluation of Medicinal Products 1998-1999
Annual report of the European Agency for Evaluation of Medicinal Products 1997
Work programme for the European Agency for the Evaluation of Medicinal Products 1997-1998
Annual report of the European Agency for Evaluation of Medicinal Products 1996
Annual report of the European Agency for Evaluation of Medicinal Products 1995